Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
S. E. Larsen, B. J. Berube, T. Pecor, E. Cross, B. P. Brown, B. Williams, E. Johnson, P. Qu, L. Carter, S. Wren, E. Kepl, C. Sydeman, N. P. King, S. L. Baldwin, R. N. Coler
This paper qualifies ELISA and neutralization assays to measure SARS-CoV-2 humoral immunity using clinical samples, evaluating antibody titers and functional neutralization capacity.
bioRxiv · Jul 2, 2021Immunology